Key Points Hims & Hers Health is expected to grow revenue sharply in 2027. Subscriber growth and rising revenue per subscriber continue to strengthen the company’s operational momentum. Deteriorating gross margins are a significant risk. 10 stocks we like better than Hims & Hers Health › Hims & Hers Health (NYSE: HIMS) is a digital health platform offering personalized care and treatments across areas such as weight loss, sexual health, hair loss, and hormonal health. Shares of the company have been volatile so far in 2026. But I think the stock could climb 55.7% from its Sept. 10 closing price of $27.47 by the end of 2026. Here's why. Missed Nvidia in 2009? This Rare Signal Is Flashing Again.
Publicznie pokazujemy glowna mysl. Utworz darmowe konto, aby czytac caly artykul, zapisac go, omowic i polaczyc z kontekstem rynkowym oraz OSINT.